Feature

Biotech has fallen

Signal to buy

These are hazardous times for investors in the UK, particularly those seeking sustainable income, writes Saracen's Scott McKenzie.

The number of foreign tourists travelling to Japan has been growing strongly for four years now and shows no signs of abating, writes Fidelity's Nicholas Price.

Authorities clamping down

As far as markets go, the outcome of the EU referendum has the potential to be far more seismic than polls before them, and one that could see stocks rallying or reeling.

Problems caused by China and central banks

With Mario Draghi extending the ECB's QE programme this month, and investors returning to US high yield following a number of recent sell-offs, managers tell Investment Week which areas of the credit sphere are likely to outperform in the coming months...

'Fearing fear itself'

Just over a month ago, volatility, as measured by the VIX index was around 26%, the highest reading since the Chinese slowdown scare of last August. The FTSE 100 was plunging, reaching its nadir of 5,500 in the morning of 11 February.